Free Trial

OptiBiotix Health (OPTI) Competitors

OptiBiotix Health logo
GBX 11.75 +0.38 (+3.30%)
As of 06:53 AM Eastern

OPTI vs. CYAN, OKYO, PHE, REVB, IGAS, ALT, CRDL, IDP, BON, and JAN

Should you be buying OptiBiotix Health stock or one of its competitors? The main competitors of OptiBiotix Health include CyanConnode (CYAN), OKYO Pharma (OKYO), PowerHouse Energy Group (PHE), Revolution Beauty Group (REVB), IGas Energy (IGAS), Altitude Group (ALT), Cordel Group (CRDL), InnovaDerma (IDP), Bonmarche (BON), and Jangada Mines (JAN). These companies are all part of the "pharmaceutical products" industry.

OptiBiotix Health vs. Its Competitors

CyanConnode (LON:CYAN) and OptiBiotix Health (LON:OPTI) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

CyanConnode has a net margin of -20.45% compared to OptiBiotix Health's net margin of -524.43%. CyanConnode's return on equity of -28.94% beat OptiBiotix Health's return on equity.

Company Net Margins Return on Equity Return on Assets
CyanConnode-20.45% -28.94% -9.06%
OptiBiotix Health -524.43%-36.76%-13.93%

29.1% of CyanConnode shares are held by institutional investors. Comparatively, 4.9% of OptiBiotix Health shares are held by institutional investors. 17.8% of CyanConnode shares are held by insiders. Comparatively, 12.0% of OptiBiotix Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, CyanConnode and CyanConnode both had 1 articles in the media. CyanConnode's average media sentiment score of 1.40 beat OptiBiotix Health's score of 0.03 indicating that CyanConnode is being referred to more favorably in the media.

Company Overall Sentiment
CyanConnode Positive
OptiBiotix Health Neutral

OptiBiotix Health has lower revenue, but higher earnings than CyanConnode. CyanConnode is trading at a lower price-to-earnings ratio than OptiBiotix Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CyanConnode£23.07M1.21-£4.72M-£1.34-5.94
OptiBiotix Health£590.01K19.51-£3.09M-£3.16-3.72

CyanConnode has a beta of 1.6, suggesting that its share price is 60% more volatile than the S&P 500. Comparatively, OptiBiotix Health has a beta of 1.71, suggesting that its share price is 71% more volatile than the S&P 500.

Summary

CyanConnode beats OptiBiotix Health on 8 of the 12 factors compared between the two stocks.

Get OptiBiotix Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPTI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OPTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPTI vs. The Competition

MetricOptiBiotix HealthBiotechnology IndustryMedical SectorLON Exchange
Market Cap£11.51M£123.51M£5.48B£2.95B
Dividend YieldN/A3.74%5.38%5.02%
P/E Ratio-3.723.2826.22141.97
Price / Sales19.513,647.72394.92214,420.17
Price / Cash8.6813.1936.4927.99
Price / Book1.5143.047.914.61
Net Income-£3.09M-£92.79M£3.15B£5.90B
7 Day Performance2.62%0.20%0.75%0.60%
1 Month Performance-8.20%2.00%3.46%4.46%
1 Year Performance-21.67%180.93%34.60%80.87%

OptiBiotix Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPTI
OptiBiotix Health
N/AGBX 11.75
+3.3%
N/A-28.1%£11.51M£590.01K-3.721Earnings Report
Gap Up
CYAN
CyanConnode
N/AGBX 7.47
+3.0%
N/A-3.5%£26.10M£23.07M-5.56100
OKYO
OKYO Pharma
N/AN/AN/AN/A£23.24MN/A-140.007Gap Down
PHE
PowerHouse Energy Group
N/AGBX 0.49
-0.6%
N/A-56.5%£22.35M£623.95K-10.994Gap Down
REVB
Revolution Beauty Group
N/AGBX 6.52
-16.2%
N/A-81.2%£20.85M£173.87M-37.9910Positive News
Gap Down
High Trading Volume
IGAS
IGas Energy
N/AN/AN/AN/A£18.97M£59.17M-148.90100Positive News
Gap Up
ALT
Altitude Group
N/AGBX 24.40
+1.7%
N/A-41.5%£17.75M£23.50M26.1150Gap Down
High Trading Volume
CRDL
Cordel Group
N/AGBX 7.21
+4.9%
N/A+68.6%£15.65M£4.83M-11.0835Gap Up
IDP
InnovaDerma
N/AN/AN/AN/A£8.14M£9.82M-3.878,720
BON
Bonmarche
N/AN/AN/AN/A£4.25M£186.15M0.91100News Coverage
JAN
Jangada Mines
N/AGBX 1.20
+4.3%
N/AN/A£3.88MN/A-5,816.771Gap Up

Related Companies and Tools


This page (LON:OPTI) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners